Latest / Decera Clinical Education Oncology Podcast
What Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Refractory Myeloma
In this podcast episode, Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, and Anthony Perissinotti, PharmD, BCOP, discuss the role, efficacy, and safety of agents targeting BCMA in the personalized care of patients with multiple myeloma after disease progression on 1 or 2 previous lines of therapy, including:
A Brief Overview of BCMA in Multiple Myeloma
Advances in BCMA-Targeted Agents in Progressing Myeloma
Selection of BCMA-Directed Therapies for Early Relapse MM
Operational Challenges Faced by Oncology Pharmacists Regarding the Incorporation of BCMA-Targeted Agents in Practice…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.